ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
22K |
7.7M |
4 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
22K
|
7.7M
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Banter and general comments
|
|
ma420
|
81 |
34K |
1 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
81
|
34K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Banter and general comments
|
|
ma420
|
81 |
34K |
0 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
81
|
34K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
922 |
325K |
4 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
922
|
325K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
ATX - Media thread
|
|
ma420
|
17 |
6.3K |
11 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
17
|
6.3K
|
11
|
|
ASX - By Stock
|
ATX |
ATX - Media thread
|
|
ma420
|
17 |
6.3K |
9 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
17
|
6.3K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: German MDS group awarded $2.5m grant for phase 2 MDS trial
|
|
ma420
|
4 |
1.3K |
15 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
4
|
1.3K
|
15
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change in substantial holding
|
|
ma420
|
6 |
1.9K |
4 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
6
|
1.9K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
ma420
|
132 |
48K |
5 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
132
|
48K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Additional Patient Response in Pancreatic Cancer Trial
|
|
ma420
|
30 |
11K |
2 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
ma420
|
132 |
48K |
14 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
132
|
48K
|
14
|
|
ASX - By Stock
|
SNT |
SNT - Media thread
|
|
ma420
|
8 |
2.6K |
6 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
8
|
2.6K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
773K |
13 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
2.2K
|
773K
|
13
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Additional Patient Response in Pancreatic Cancer Trial
|
|
ma420
|
30 |
11K |
13 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
30
|
11K
|
13
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Additional Patient Response in Pancreatic Cancer Trial
|
|
ma420
|
30 |
11K |
1 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
30
|
11K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
28 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
558
|
224K
|
28
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Additional Patient Response in Pancreatic Cancer Trial
|
|
ma420
|
30 |
11K |
9 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
30
|
11K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
ma420
|
21 |
6.1K |
7 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
21
|
6.1K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
240K |
13 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
663
|
240K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Date & Director Nominations Closing Date for AGM
|
|
ma420
|
17 |
4.8K |
3 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
17
|
4.8K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
922 |
325K |
1 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
922
|
325K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
922 |
325K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
922
|
325K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
558
|
224K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
922 |
325K |
6 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
922
|
325K
|
6
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
214 |
121K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
214
|
121K
|
8
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
214 |
121K |
13 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
214
|
121K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
922 |
325K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
922
|
325K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
4.0M |
2 |
05/08/24 |
05/08/24 |
General
|
11K
|
4.0M
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
240K |
10 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
663
|
240K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Change of Director's Interest Notice - Biggin
|
|
ma420
|
1 |
969 |
9 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1
|
969
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
ma420
|
36 |
7.9K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
36
|
7.9K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
ma420
|
36 |
7.9K |
4 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
36
|
7.9K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
ma420
|
117 |
30K |
6 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
117
|
30K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
ma420
|
81 |
23K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
81
|
23K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
240K |
5 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
663
|
240K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
663 |
240K |
24 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
663
|
240K
|
24
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
4 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
558
|
224K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
13 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
558
|
224K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
16 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
558
|
224K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
3 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
558
|
224K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
1 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
558
|
224K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
14 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
558
|
224K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
9 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
558
|
224K
|
9
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Placement & ANREO to raise up to 13.6m
|
|
ma420
|
11 |
4.1K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
11
|
4.1K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Change of Director's Interest Notice - Taylor
|
|
ma420
|
6 |
1.8K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.8K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
12 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
558
|
224K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
8 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
558
|
224K
|
8
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Placement & ANREO to raise up to 13.6m
|
|
ma420
|
11 |
4.1K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
11
|
4.1K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ma420
|
132 |
32K |
8 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
132
|
32K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
558 |
224K |
21 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
558
|
224K
|
21
|
|